nodes	percent_of_prediction	percent_of_DWPC	metapath
Sorafenib—ABCG2—gout	0.344	1	CbGaD
Sorafenib—UGT1A1—Naproxen—gout	0.0539	0.112	CbGbCtD
Sorafenib—UGT1A9—Indomethacin—gout	0.0436	0.0904	CbGbCtD
Sorafenib—ABCC4—Probenecid—gout	0.0374	0.0776	CbGbCtD
Sorafenib—ABCC4—Indomethacin—gout	0.0364	0.0756	CbGbCtD
Sorafenib—UGT1A1—Indomethacin—gout	0.0356	0.0739	CbGbCtD
Sorafenib—ABCC2—Probenecid—gout	0.0223	0.0462	CbGbCtD
Sorafenib—ABCC2—Indomethacin—gout	0.0217	0.045	CbGbCtD
Sorafenib—CYP2B6—Colchicine—gout	0.0158	0.0328	CbGbCtD
Sorafenib—CYP2C8—Naproxen—gout	0.0158	0.0328	CbGbCtD
Sorafenib—CYP1A2—Naproxen—gout	0.0122	0.0254	CbGbCtD
Sorafenib—ABCG2—Hydrocortisone—gout	0.0121	0.025	CbGbCtD
Sorafenib—CYP2C8—Colchicine—gout	0.012	0.0248	CbGbCtD
Sorafenib—CYP2C9—Naproxen—gout	0.011	0.0229	CbGbCtD
Sorafenib—CYP2C8—Probenecid—gout	0.0107	0.0222	CbGbCtD
Sorafenib—CYP2C19—Probenecid—gout	0.00899	0.0187	CbGbCtD
Sorafenib—CYP3A7-CYP3A51P—Hydrocortisone—gout	0.00892	0.0185	CbGbCtD
Sorafenib—CYP3A7—Hydrocortisone—gout	0.00892	0.0185	CbGbCtD
Sorafenib—CYP2C19—Indomethacin—gout	0.00876	0.0182	CbGbCtD
Sorafenib—CYP2C9—Colchicine—gout	0.00835	0.0173	CbGbCtD
Sorafenib—ABCB1—Colchicine—gout	0.0081	0.0168	CbGbCtD
Sorafenib—CYP2C9—Probenecid—gout	0.00748	0.0155	CbGbCtD
Sorafenib—CYP2C9—Indomethacin—gout	0.00728	0.0151	CbGbCtD
Sorafenib—ABCB1—Probenecid—gout	0.00726	0.0151	CbGbCtD
Sorafenib—ABCB1—Methylprednisolone—gout	0.00716	0.0148	CbGbCtD
Sorafenib—ABCB1—Indomethacin—gout	0.00707	0.0147	CbGbCtD
Sorafenib—CYP3A5—Hydrocortisone—gout	0.00669	0.0139	CbGbCtD
Sorafenib—CYP2C8—Hydrocortisone—gout	0.00643	0.0133	CbGbCtD
Sorafenib—CYP2C19—Prednisone—gout	0.00538	0.0112	CbGbCtD
Sorafenib—CYP3A4—Colchicine—gout	0.00486	0.0101	CbGbCtD
Sorafenib—ABCB1—Prednisolone—gout	0.00459	0.00953	CbGbCtD
Sorafenib—ABCB1—Hydrocortisone—gout	0.00435	0.00903	CbGbCtD
Sorafenib—CYP3A4—Probenecid—gout	0.00435	0.00902	CbGbCtD
Sorafenib—ABCB1—Prednisone—gout	0.00434	0.009	CbGbCtD
Sorafenib—CYP3A4—Methylprednisolone—gout	0.00429	0.0089	CbGbCtD
Sorafenib—CYP3A4—Prednisolone—gout	0.00275	0.00571	CbGbCtD
Sorafenib—CYP3A4—Hydrocortisone—gout	0.00261	0.00541	CbGbCtD
Sorafenib—CYP3A4—Prednisone—gout	0.0026	0.00539	CbGbCtD
Sorafenib—Regorafenib—ABCG2—gout	0.00225	0.558	CrCbGaD
Sorafenib—Vismodegib—ABCG2—gout	0.00178	0.442	CrCbGaD
Sorafenib—MUSK—tendon—gout	0.0013	0.151	CbGeAlD
Sorafenib—TAOK2—tendon—gout	0.000551	0.0642	CbGeAlD
Sorafenib—AURKC—tendon—gout	0.000547	0.0637	CbGeAlD
Sorafenib—ZAK—tendon—gout	0.00048	0.0559	CbGeAlD
Sorafenib—HIPK3—tendon—gout	0.00047	0.0547	CbGeAlD
Sorafenib—BRAF—tendon—gout	0.000421	0.049	CbGeAlD
Sorafenib—EPHX2—tendon—gout	0.000402	0.0469	CbGeAlD
Sorafenib—FGFR1—tendon—gout	0.000358	0.0417	CbGeAlD
Sorafenib—MAP3K7—tendon—gout	0.000339	0.0395	CbGeAlD
Sorafenib—MKNK2—tendon—gout	0.000328	0.0382	CbGeAlD
Sorafenib—RET—tendon—gout	0.00032	0.0373	CbGeAlD
Sorafenib—RALBP1—tendon—gout	0.000297	0.0345	CbGeAlD
Sorafenib—FLT1—tendon—gout	0.000282	0.0329	CbGeAlD
Sorafenib—RAF1—tendon—gout	0.00028	0.0327	CbGeAlD
Sorafenib—EPHB6—tendon—gout	0.000279	0.0325	CbGeAlD
Sorafenib—MKNK1—MAPK Signaling Pathway—CASP1—gout	0.000275	0.00898	CbGpPWpGaD
Sorafenib—STK10—tendon—gout	0.000267	0.0311	CbGeAlD
Sorafenib—PDGFRA—tendon—gout	0.000264	0.0308	CbGeAlD
Sorafenib—UGT1A9—NRF2 pathway—SLC2A9—gout	0.000243	0.00794	CbGpPWpGaD
Sorafenib—UGT1A1—NRF2 pathway—SLC2A9—gout	0.000243	0.00794	CbGpPWpGaD
Sorafenib—KDR—tendon—gout	0.000238	0.0278	CbGeAlD
Sorafenib—MAP2K5—tendon—gout	0.000238	0.0278	CbGeAlD
Sorafenib—ABCC2—NRF2 pathway—SLC2A9—gout	0.000237	0.00775	CbGpPWpGaD
Sorafenib—CYP3A4—Irinotecan Pathway—ABCG2—gout	0.000235	0.0077	CbGpPWpGaD
Sorafenib—CSF1R—tendon—gout	0.000233	0.0271	CbGeAlD
Sorafenib—EPHX2—Metabolism—BCKDHA—gout	0.000214	0.00701	CbGpPWpGaD
Sorafenib—ABCC4—Hemostasis—LRRC16A—gout	0.000213	0.00696	CbGpPWpGaD
Sorafenib—PDGFRB—tendon—gout	0.000206	0.024	CbGeAlD
Sorafenib—MAP3K7—Signaling by Interleukins—CASP1—gout	0.000182	0.00594	CbGpPWpGaD
Sorafenib—RAF1—Leptin signaling pathway—IL1RN—gout	0.000179	0.00585	CbGpPWpGaD
Sorafenib—RAF1—Hemostasis—LRRC16A—gout	0.000179	0.00585	CbGpPWpGaD
Sorafenib—Neuropathy—Prednisone—gout	0.000179	0.00137	CcSEcCtD
Sorafenib—Dyspepsia—Allopurinol—gout	0.000178	0.00136	CcSEcCtD
Sorafenib—Urticaria—Indomethacin—gout	0.000177	0.00135	CcSEcCtD
Sorafenib—Anaphylactic shock—Naproxen—gout	0.000176	0.00135	CcSEcCtD
Sorafenib—Mood swings—Hydrocortisone—gout	0.000176	0.00135	CcSEcCtD
Sorafenib—MAP3K7—Signaling by Interleukins—IL1RN—gout	0.000176	0.00575	CbGpPWpGaD
Sorafenib—Abdominal pain—Indomethacin—gout	0.000176	0.00134	CcSEcCtD
Sorafenib—Body temperature increased—Indomethacin—gout	0.000176	0.00134	CcSEcCtD
Sorafenib—Decreased appetite—Allopurinol—gout	0.000175	0.00134	CcSEcCtD
Sorafenib—Infection—Naproxen—gout	0.000175	0.00134	CcSEcCtD
Sorafenib—EPHX2—Metabolism—PRPS1—gout	0.000175	0.00572	CbGpPWpGaD
Sorafenib—EPHX2—Metabolism—PRPS2—gout	0.000175	0.00572	CbGpPWpGaD
Sorafenib—EPHX2—Metabolism—HPRT1—gout	0.000175	0.00572	CbGpPWpGaD
Sorafenib—Dry skin—Prednisolone—gout	0.000174	0.00133	CcSEcCtD
Sorafenib—Gastrointestinal disorder—Allopurinol—gout	0.000174	0.00133	CcSEcCtD
Sorafenib—Shock—Naproxen—gout	0.000173	0.00133	CcSEcCtD
Sorafenib—Nervous system disorder—Naproxen—gout	0.000173	0.00132	CcSEcCtD
Sorafenib—Constipation—Allopurinol—gout	0.000172	0.00132	CcSEcCtD
Sorafenib—Pain—Allopurinol—gout	0.000172	0.00132	CcSEcCtD
Sorafenib—Thrombocytopenia—Naproxen—gout	0.000172	0.00132	CcSEcCtD
Sorafenib—Hypersensitivity—Colchicine—gout	0.000172	0.00132	CcSEcCtD
Sorafenib—Skin disorder—Naproxen—gout	0.000171	0.00131	CcSEcCtD
Sorafenib—Dry skin—Hydrocortisone—gout	0.00017	0.0013	CcSEcCtD
Sorafenib—MKNK1—Disease—PRPS2—gout	0.00017	0.00556	CbGpPWpGaD
Sorafenib—MKNK1—Disease—PRPS1—gout	0.00017	0.00556	CbGpPWpGaD
Sorafenib—Abdominal pain upper—Hydrocortisone—gout	0.00017	0.0013	CcSEcCtD
Sorafenib—Hypokalaemia—Hydrocortisone—gout	0.000169	0.00129	CcSEcCtD
Sorafenib—MAP2K5—MAPK Signaling Pathway—CASP1—gout	0.000169	0.00552	CbGpPWpGaD
Sorafenib—Anorexia—Naproxen—gout	0.000168	0.00128	CcSEcCtD
Sorafenib—Asthenia—Colchicine—gout	0.000168	0.00128	CcSEcCtD
Sorafenib—Mood swings—Methylprednisolone—gout	0.000165	0.00127	CcSEcCtD
Sorafenib—Gastrointestinal pain—Allopurinol—gout	0.000165	0.00126	CcSEcCtD
Sorafenib—ABCC4—tendon—gout	0.000164	0.0191	CbGeAlD
Sorafenib—Alanine aminotransferase increased—Hydrocortisone—gout	0.000164	0.00125	CcSEcCtD
Sorafenib—Hypersensitivity—Indomethacin—gout	0.000164	0.00125	CcSEcCtD
Sorafenib—HTR2B—tendon—gout	0.000163	0.019	CbGeAlD
Sorafenib—Pancreatitis—Prednisolone—gout	0.000161	0.00123	CcSEcCtD
Sorafenib—Musculoskeletal discomfort—Naproxen—gout	0.00016	0.00123	CcSEcCtD
Sorafenib—Urticaria—Allopurinol—gout	0.00016	0.00123	CcSEcCtD
Sorafenib—Diarrhoea—Colchicine—gout	0.00016	0.00123	CcSEcCtD
Sorafenib—Asthenia—Indomethacin—gout	0.000159	0.00122	CcSEcCtD
Sorafenib—Abdominal pain—Allopurinol—gout	0.000159	0.00122	CcSEcCtD
Sorafenib—Body temperature increased—Allopurinol—gout	0.000159	0.00122	CcSEcCtD
Sorafenib—ABCC2—tendon—gout	0.000159	0.0185	CbGeAlD
Sorafenib—Breast disorder—Methylprednisolone—gout	0.000158	0.00121	CcSEcCtD
Sorafenib—Pancreatitis—Hydrocortisone—gout	0.000157	0.00121	CcSEcCtD
Sorafenib—Pruritus—Indomethacin—gout	0.000157	0.0012	CcSEcCtD
Sorafenib—Dyspnoea—Naproxen—gout	0.000157	0.0012	CcSEcCtD
Sorafenib—ABCC4—Transmembrane transport of small molecules—SLC17A3—gout	0.000157	0.00512	CbGpPWpGaD
Sorafenib—Dyspepsia—Naproxen—gout	0.000155	0.00119	CcSEcCtD
Sorafenib—Alanine aminotransferase increased—Methylprednisolone—gout	0.000154	0.00118	CcSEcCtD
Sorafenib—Decreased appetite—Naproxen—gout	0.000153	0.00117	CcSEcCtD
Sorafenib—Cardiac failure congestive—Prednisone—gout	0.000152	0.00117	CcSEcCtD
Sorafenib—Diarrhoea—Indomethacin—gout	0.000152	0.00116	CcSEcCtD
Sorafenib—Gastrointestinal disorder—Naproxen—gout	0.000152	0.00116	CcSEcCtD
Sorafenib—Fatigue—Naproxen—gout	0.000152	0.00116	CcSEcCtD
Sorafenib—Constipation—Naproxen—gout	0.000151	0.00115	CcSEcCtD
Sorafenib—Pain—Naproxen—gout	0.000151	0.00115	CcSEcCtD
Sorafenib—Vomiting—Colchicine—gout	0.000149	0.00114	CcSEcCtD
Sorafenib—Hypersensitivity—Allopurinol—gout	0.000149	0.00114	CcSEcCtD
Sorafenib—Pancreatitis—Methylprednisolone—gout	0.000148	0.00113	CcSEcCtD
Sorafenib—Rash—Colchicine—gout	0.000147	0.00113	CcSEcCtD
Sorafenib—Dermatitis—Colchicine—gout	0.000147	0.00113	CcSEcCtD
Sorafenib—Dizziness—Indomethacin—gout	0.000147	0.00112	CcSEcCtD
Sorafenib—Headache—Colchicine—gout	0.000147	0.00112	CcSEcCtD
Sorafenib—Weight decreased—Hydrocortisone—gout	0.000145	0.00111	CcSEcCtD
Sorafenib—Asthenia—Allopurinol—gout	0.000145	0.00111	CcSEcCtD
Sorafenib—Acute coronary syndrome—Prednisolone—gout	0.000145	0.00111	CcSEcCtD
Sorafenib—Gastrointestinal pain—Naproxen—gout	0.000144	0.0011	CcSEcCtD
Sorafenib—Myocardial infarction—Prednisolone—gout	0.000144	0.0011	CcSEcCtD
Sorafenib—Neuropathy peripheral—Prednisolone—gout	0.000144	0.0011	CcSEcCtD
Sorafenib—Infestation—Hydrocortisone—gout	0.000143	0.0011	CcSEcCtD
Sorafenib—Infestation NOS—Hydrocortisone—gout	0.000143	0.0011	CcSEcCtD
Sorafenib—Pruritus—Allopurinol—gout	0.000143	0.00109	CcSEcCtD
Sorafenib—Cardiac failure—Prednisone—gout	0.000142	0.00108	CcSEcCtD
Sorafenib—Vomiting—Indomethacin—gout	0.000141	0.00108	CcSEcCtD
Sorafenib—Acute coronary syndrome—Hydrocortisone—gout	0.000141	0.00108	CcSEcCtD
Sorafenib—Neuropathy peripheral—Hydrocortisone—gout	0.00014	0.00107	CcSEcCtD
Sorafenib—Myocardial infarction—Hydrocortisone—gout	0.00014	0.00107	CcSEcCtD
Sorafenib—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—ABCG2—gout	0.00014	0.00458	CbGpPWpGaD
Sorafenib—BRAF—MAPK Signaling Pathway—CASP1—gout	0.00014	0.00458	CbGpPWpGaD
Sorafenib—Rash—Indomethacin—gout	0.00014	0.00107	CcSEcCtD
Sorafenib—Dermatitis—Indomethacin—gout	0.00014	0.00107	CcSEcCtD
Sorafenib—Urticaria—Naproxen—gout	0.00014	0.00107	CcSEcCtD
Sorafenib—Headache—Indomethacin—gout	0.000139	0.00107	CcSEcCtD
Sorafenib—Body temperature increased—Naproxen—gout	0.000139	0.00107	CcSEcCtD
Sorafenib—Abdominal pain—Naproxen—gout	0.000139	0.00107	CcSEcCtD
Sorafenib—Nausea—Colchicine—gout	0.000139	0.00106	CcSEcCtD
Sorafenib—RAF1—Signaling by Interleukins—CASP1—gout	0.000138	0.00452	CbGpPWpGaD
Sorafenib—Diarrhoea—Allopurinol—gout	0.000138	0.00106	CcSEcCtD
Sorafenib—Infestation—Methylprednisolone—gout	0.000135	0.00103	CcSEcCtD
Sorafenib—Infestation NOS—Methylprednisolone—gout	0.000135	0.00103	CcSEcCtD
Sorafenib—RAF1—Signaling by Interleukins—IL1RN—gout	0.000134	0.00437	CbGpPWpGaD
Sorafenib—Dizziness—Allopurinol—gout	0.000133	0.00102	CcSEcCtD
Sorafenib—Acute coronary syndrome—Methylprednisolone—gout	0.000133	0.00102	CcSEcCtD
Sorafenib—Haemoglobin—Prednisolone—gout	0.000132	0.00101	CcSEcCtD
Sorafenib—ABCC2—Transmembrane transport of small molecules—SLC17A3—gout	0.000132	0.00432	CbGpPWpGaD
Sorafenib—Nausea—Indomethacin—gout	0.000132	0.00101	CcSEcCtD
Sorafenib—Myocardial infarction—Methylprednisolone—gout	0.000132	0.00101	CcSEcCtD
Sorafenib—Neuropathy peripheral—Methylprednisolone—gout	0.000132	0.00101	CcSEcCtD
Sorafenib—RAF1—Transmembrane transport of small molecules—SLC17A3—gout	0.000132	0.00431	CbGpPWpGaD
Sorafenib—Haemorrhage—Prednisolone—gout	0.000132	0.00101	CcSEcCtD
Sorafenib—Mood swings—Prednisone—gout	0.000131	0.001	CcSEcCtD
Sorafenib—Hypersensitivity—Naproxen—gout	0.00013	0.000993	CcSEcCtD
Sorafenib—Haemoglobin—Hydrocortisone—gout	0.000129	0.000989	CcSEcCtD
Sorafenib—Haemorrhage—Hydrocortisone—gout	0.000129	0.000984	CcSEcCtD
Sorafenib—Vomiting—Allopurinol—gout	0.000128	0.000981	CcSEcCtD
Sorafenib—ABCC4—Transmembrane transport of small molecules—SLC22A11—gout	0.000128	0.00418	CbGpPWpGaD
Sorafenib—ABCC4—Transmembrane transport of small molecules—SLC17A1—gout	0.000128	0.00418	CbGpPWpGaD
Sorafenib—MAP3K7—MAPK Signaling Pathway—CASP1—gout	0.000128	0.00417	CbGpPWpGaD
Sorafenib—Rash—Allopurinol—gout	0.000127	0.000973	CcSEcCtD
Sorafenib—Dermatitis—Allopurinol—gout	0.000127	0.000972	CcSEcCtD
Sorafenib—Dry skin—Prednisone—gout	0.000127	0.00097	CcSEcCtD
Sorafenib—Headache—Allopurinol—gout	0.000126	0.000967	CcSEcCtD
Sorafenib—Asthenia—Naproxen—gout	0.000126	0.000967	CcSEcCtD
Sorafenib—Connective tissue disorder—Hydrocortisone—gout	0.000126	0.000967	CcSEcCtD
Sorafenib—Hypokalaemia—Prednisone—gout	0.000126	0.000963	CcSEcCtD
Sorafenib—Pruritus—Naproxen—gout	0.000125	0.000954	CcSEcCtD
Sorafenib—MAPK11—Glucocorticoid receptor regulatory network—POMC—gout	0.000123	0.00402	CbGpPWpGaD
Sorafenib—Alanine aminotransferase increased—Prednisone—gout	0.000122	0.000933	CcSEcCtD
Sorafenib—Haemoglobin—Methylprednisolone—gout	0.000121	0.000929	CcSEcCtD
Sorafenib—FGFR1—MAPK Signaling Pathway—CASP1—gout	0.000121	0.00396	CbGpPWpGaD
Sorafenib—Haemorrhage—Methylprednisolone—gout	0.000121	0.000924	CcSEcCtD
Sorafenib—Diarrhoea—Naproxen—gout	0.00012	0.000922	CcSEcCtD
Sorafenib—CDK7—Disease—PRPS2—gout	0.00012	0.00392	CbGpPWpGaD
Sorafenib—CDK7—Disease—PRPS1—gout	0.00012	0.00392	CbGpPWpGaD
Sorafenib—Nausea—Allopurinol—gout	0.00012	0.000917	CcSEcCtD
Sorafenib—Connective tissue disorder—Methylprednisolone—gout	0.000119	0.000908	CcSEcCtD
Sorafenib—Arrhythmia—Prednisolone—gout	0.000118	0.0009	CcSEcCtD
Sorafenib—Pancreatitis—Prednisone—gout	0.000117	0.000897	CcSEcCtD
Sorafenib—Dizziness—Naproxen—gout	0.000116	0.000891	CcSEcCtD
Sorafenib—Immune system disorder—Hydrocortisone—gout	0.000116	0.000889	CcSEcCtD
Sorafenib—ABCG2—Transmembrane transport of small molecules—SLC17A3—gout	0.000115	0.00376	CbGpPWpGaD
Sorafenib—Arrhythmia—Hydrocortisone—gout	0.000115	0.000879	CcSEcCtD
Sorafenib—Erythema—Prednisolone—gout	0.000115	0.000877	CcSEcCtD
Sorafenib—Mental disorder—Hydrocortisone—gout	0.000113	0.000862	CcSEcCtD
Sorafenib—Cardiac disorder—Methylprednisolone—gout	0.000112	0.000858	CcSEcCtD
Sorafenib—Vomiting—Naproxen—gout	0.000112	0.000857	CcSEcCtD
Sorafenib—Malnutrition—Hydrocortisone—gout	0.000112	0.000857	CcSEcCtD
Sorafenib—Erythema—Hydrocortisone—gout	0.000112	0.000857	CcSEcCtD
Sorafenib—Neutropenia—Prednisone—gout	0.000112	0.000855	CcSEcCtD
Sorafenib—BRAF—Corticotropin-releasing hormone—POMC—gout	0.000111	0.00364	CbGpPWpGaD
Sorafenib—Rash—Naproxen—gout	0.000111	0.00085	CcSEcCtD
Sorafenib—Dermatitis—Naproxen—gout	0.000111	0.000849	CcSEcCtD
Sorafenib—ABCB1—HIF-1-alpha transcription factor network—ABCG2—gout	0.00011	0.00361	CbGpPWpGaD
Sorafenib—Headache—Naproxen—gout	0.00011	0.000844	CcSEcCtD
Sorafenib—Erectile dysfunction—Prednisone—gout	0.00011	0.000842	CcSEcCtD
Sorafenib—Angiopathy—Methylprednisolone—gout	0.00011	0.000839	CcSEcCtD
Sorafenib—Immune system disorder—Methylprednisolone—gout	0.000109	0.000835	CcSEcCtD
Sorafenib—Mediastinal disorder—Methylprednisolone—gout	0.000109	0.000833	CcSEcCtD
Sorafenib—PDGFRB—MAPK Signaling Pathway—CASP1—gout	0.000109	0.00356	CbGpPWpGaD
Sorafenib—Weight decreased—Prednisone—gout	0.000108	0.000827	CcSEcCtD
Sorafenib—MAPK11—Innate Immune System—NLRP3—gout	0.000108	0.00353	CbGpPWpGaD
Sorafenib—Arrhythmia—Methylprednisolone—gout	0.000108	0.000826	CcSEcCtD
Sorafenib—ABCC2—Transmembrane transport of small molecules—SLC17A1—gout	0.000108	0.00352	CbGpPWpGaD
Sorafenib—ABCC2—Transmembrane transport of small molecules—SLC22A11—gout	0.000108	0.00352	CbGpPWpGaD
Sorafenib—RAF1—Transmembrane transport of small molecules—SLC22A11—gout	0.000107	0.00351	CbGpPWpGaD
Sorafenib—RAF1—Transmembrane transport of small molecules—SLC17A1—gout	0.000107	0.00351	CbGpPWpGaD
Sorafenib—Mental disorder—Methylprednisolone—gout	0.000106	0.00081	CcSEcCtD
Sorafenib—Erythema—Methylprednisolone—gout	0.000105	0.000805	CcSEcCtD
Sorafenib—Malnutrition—Methylprednisolone—gout	0.000105	0.000805	CcSEcCtD
Sorafenib—Acute coronary syndrome—Prednisone—gout	0.000105	0.000804	CcSEcCtD
Sorafenib—Angioedema—Prednisolone—gout	0.000105	0.000801	CcSEcCtD
Sorafenib—Nausea—Naproxen—gout	0.000105	0.000801	CcSEcCtD
Sorafenib—Myocardial infarction—Prednisone—gout	0.000104	0.000799	CcSEcCtD
Sorafenib—Neuropathy peripheral—Prednisone—gout	0.000104	0.000799	CcSEcCtD
Sorafenib—Syncope—Prednisolone—gout	0.000103	0.000786	CcSEcCtD
Sorafenib—Angioedema—Hydrocortisone—gout	0.000102	0.000783	CcSEcCtD
Sorafenib—Loss of consciousness—Prednisolone—gout	0.000101	0.000771	CcSEcCtD
Sorafenib—Syncope—Hydrocortisone—gout	0.0001	0.000768	CcSEcCtD
Sorafenib—Hypertension—Prednisolone—gout	9.89e-05	0.000757	CcSEcCtD
Sorafenib—Loss of consciousness—Hydrocortisone—gout	9.83e-05	0.000753	CcSEcCtD
Sorafenib—KIT—Innate Immune System—NLRP3—gout	9.73e-05	0.00318	CbGpPWpGaD
Sorafenib—MAP3K7—Innate Immune System—NLRP3—gout	9.73e-05	0.00318	CbGpPWpGaD
Sorafenib—RAF1—MAPK Signaling Pathway—CASP1—gout	9.7e-05	0.00317	CbGpPWpGaD
Sorafenib—ABCC4—Transmembrane transport of small molecules—SLC22A12—gout	9.68e-05	0.00317	CbGpPWpGaD
Sorafenib—Hypertension—Hydrocortisone—gout	9.66e-05	0.000739	CcSEcCtD
Sorafenib—Haemoglobin—Prednisone—gout	9.61e-05	0.000736	CcSEcCtD
Sorafenib—Angioedema—Methylprednisolone—gout	9.61e-05	0.000735	CcSEcCtD
Sorafenib—Haemorrhage—Prednisone—gout	9.56e-05	0.000732	CcSEcCtD
Sorafenib—Myalgia—Hydrocortisone—gout	9.53e-05	0.000729	CcSEcCtD
Sorafenib—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—gout	9.46e-05	0.000724	CcSEcCtD
Sorafenib—Syncope—Methylprednisolone—gout	9.43e-05	0.000722	CcSEcCtD
Sorafenib—Connective tissue disorder—Prednisone—gout	9.4e-05	0.000719	CcSEcCtD
Sorafenib—ABCG2—Transmembrane transport of small molecules—SLC22A11—gout	9.37e-05	0.00306	CbGpPWpGaD
Sorafenib—ABCG2—Transmembrane transport of small molecules—SLC17A1—gout	9.37e-05	0.00306	CbGpPWpGaD
Sorafenib—CYP3A7—Cytochrome P450 - arranged by substrate type—POMC—gout	9.36e-05	0.00306	CbGpPWpGaD
Sorafenib—Anaphylactic shock—Prednisolone—gout	9.35e-05	0.000716	CcSEcCtD
Sorafenib—Loss of consciousness—Methylprednisolone—gout	9.24e-05	0.000707	CcSEcCtD
Sorafenib—FGFR1—Innate Immune System—NLRP3—gout	9.24e-05	0.00302	CbGpPWpGaD
Sorafenib—PDGFRA—Innate Immune System—NLRP3—gout	9.22e-05	0.00301	CbGpPWpGaD
Sorafenib—Shock—Prednisolone—gout	9.2e-05	0.000704	CcSEcCtD
Sorafenib—Anaphylactic shock—Hydrocortisone—gout	9.13e-05	0.000699	CcSEcCtD
Sorafenib—Hypertension—Methylprednisolone—gout	9.08e-05	0.000695	CcSEcCtD
Sorafenib—Infection—Hydrocortisone—gout	9.07e-05	0.000694	CcSEcCtD
Sorafenib—ABCC4—Transmembrane transport of small molecules—SLC2A9—gout	9e-05	0.00294	CbGpPWpGaD
Sorafenib—Shock—Hydrocortisone—gout	8.98e-05	0.000688	CcSEcCtD
Sorafenib—Nervous system disorder—Hydrocortisone—gout	8.96e-05	0.000686	CcSEcCtD
Sorafenib—Arthralgia—Methylprednisolone—gout	8.95e-05	0.000685	CcSEcCtD
Sorafenib—Myalgia—Methylprednisolone—gout	8.95e-05	0.000685	CcSEcCtD
Sorafenib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—gout	8.89e-05	0.00068	CcSEcCtD
Sorafenib—Flushing—Prednisone—gout	8.88e-05	0.000679	CcSEcCtD
Sorafenib—Skin disorder—Hydrocortisone—gout	8.87e-05	0.000679	CcSEcCtD
Sorafenib—Anorexia—Hydrocortisone—gout	8.7e-05	0.000666	CcSEcCtD
Sorafenib—BRAF—Disease—PRPS2—gout	8.68e-05	0.00284	CbGpPWpGaD
Sorafenib—BRAF—Disease—PRPS1—gout	8.68e-05	0.00284	CbGpPWpGaD
Sorafenib—Angiopathy—Prednisone—gout	8.68e-05	0.000664	CcSEcCtD
Sorafenib—Immune system disorder—Prednisone—gout	8.64e-05	0.000661	CcSEcCtD
Sorafenib—Anaphylactic shock—Methylprednisolone—gout	8.58e-05	0.000657	CcSEcCtD
Sorafenib—Arrhythmia—Prednisone—gout	8.54e-05	0.000654	CcSEcCtD
Sorafenib—Infection—Methylprednisolone—gout	8.52e-05	0.000652	CcSEcCtD
Sorafenib—MAP3K7—Cytokine Signaling in Immune system—CASP1—gout	8.48e-05	0.00277	CbGpPWpGaD
Sorafenib—Alopecia—Prednisone—gout	8.45e-05	0.000647	CcSEcCtD
Sorafenib—Shock—Methylprednisolone—gout	8.44e-05	0.000646	CcSEcCtD
Sorafenib—Nervous system disorder—Methylprednisolone—gout	8.41e-05	0.000644	CcSEcCtD
Sorafenib—Mental disorder—Prednisone—gout	8.38e-05	0.000641	CcSEcCtD
Sorafenib—Skin disorder—Methylprednisolone—gout	8.33e-05	0.000638	CcSEcCtD
Sorafenib—Malnutrition—Prednisone—gout	8.32e-05	0.000637	CcSEcCtD
Sorafenib—Erythema—Prednisone—gout	8.32e-05	0.000637	CcSEcCtD
Sorafenib—Musculoskeletal discomfort—Hydrocortisone—gout	8.32e-05	0.000637	CcSEcCtD
Sorafenib—PDGFRB—Innate Immune System—NLRP3—gout	8.3e-05	0.00271	CbGpPWpGaD
Sorafenib—MAP3K7—Cytokine Signaling in Immune system—IL1RN—gout	8.21e-05	0.00269	CbGpPWpGaD
Sorafenib—ABCC2—Transmembrane transport of small molecules—SLC22A12—gout	8.16e-05	0.00267	CbGpPWpGaD
Sorafenib—RAF1—Transmembrane transport of small molecules—SLC22A12—gout	8.14e-05	0.00266	CbGpPWpGaD
Sorafenib—Dyspepsia—Hydrocortisone—gout	8.04e-05	0.000615	CcSEcCtD
Sorafenib—Pain—Prednisolone—gout	8e-05	0.000612	CcSEcCtD
Sorafenib—Decreased appetite—Hydrocortisone—gout	7.94e-05	0.000608	CcSEcCtD
Sorafenib—KIT—Disease—PRPS1—gout	7.9e-05	0.00258	CbGpPWpGaD
Sorafenib—KIT—Disease—PRPS2—gout	7.9e-05	0.00258	CbGpPWpGaD
Sorafenib—Gastrointestinal disorder—Hydrocortisone—gout	7.88e-05	0.000603	CcSEcCtD
Sorafenib—Fatigue—Hydrocortisone—gout	7.87e-05	0.000603	CcSEcCtD
Sorafenib—Musculoskeletal discomfort—Methylprednisolone—gout	7.82e-05	0.000598	CcSEcCtD
Sorafenib—Pain—Hydrocortisone—gout	7.81e-05	0.000598	CcSEcCtD
Sorafenib—Anaemia—Prednisone—gout	7.69e-05	0.000589	CcSEcCtD
Sorafenib—RAF1—Corticotropin-releasing hormone—POMC—gout	7.69e-05	0.00252	CbGpPWpGaD
Sorafenib—Angioedema—Prednisone—gout	7.61e-05	0.000582	CcSEcCtD
Sorafenib—ABCC2—Transmembrane transport of small molecules—SLC2A9—gout	7.59e-05	0.00248	CbGpPWpGaD
Sorafenib—CYP3A7—Phase 1 - Functionalization of compounds—POMC—gout	7.59e-05	0.00248	CbGpPWpGaD
Sorafenib—RAF1—Transmembrane transport of small molecules—SLC2A9—gout	7.57e-05	0.00247	CbGpPWpGaD
Sorafenib—Dyspepsia—Methylprednisolone—gout	7.55e-05	0.000578	CcSEcCtD
Sorafenib—FGFR1—Disease—PRPS1—gout	7.5e-05	0.00245	CbGpPWpGaD
Sorafenib—FGFR1—Disease—PRPS2—gout	7.5e-05	0.00245	CbGpPWpGaD
Sorafenib—PDGFRA—Disease—PRPS2—gout	7.48e-05	0.00245	CbGpPWpGaD
Sorafenib—PDGFRA—Disease—PRPS1—gout	7.48e-05	0.00245	CbGpPWpGaD
Sorafenib—Gastrointestinal pain—Hydrocortisone—gout	7.47e-05	0.000572	CcSEcCtD
Sorafenib—Syncope—Prednisone—gout	7.47e-05	0.000571	CcSEcCtD
Sorafenib—Urticaria—Prednisolone—gout	7.43e-05	0.000569	CcSEcCtD
Sorafenib—RAF1—Innate Immune System—NLRP3—gout	7.4e-05	0.00242	CbGpPWpGaD
Sorafenib—Fatigue—Methylprednisolone—gout	7.4e-05	0.000566	CcSEcCtD
Sorafenib—Loss of consciousness—Prednisone—gout	7.32e-05	0.00056	CcSEcCtD
Sorafenib—Urticaria—Hydrocortisone—gout	7.25e-05	0.000555	CcSEcCtD
Sorafenib—Abdominal pain—Hydrocortisone—gout	7.22e-05	0.000553	CcSEcCtD
Sorafenib—Body temperature increased—Hydrocortisone—gout	7.22e-05	0.000553	CcSEcCtD
Sorafenib—Hypertension—Prednisone—gout	7.19e-05	0.00055	CcSEcCtD
Sorafenib—ABCG2—Transmembrane transport of small molecules—SLC22A12—gout	7.1e-05	0.00232	CbGpPWpGaD
Sorafenib—Myalgia—Prednisone—gout	7.09e-05	0.000543	CcSEcCtD
Sorafenib—Arthralgia—Prednisone—gout	7.09e-05	0.000543	CcSEcCtD
Sorafenib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—gout	7.04e-05	0.000539	CcSEcCtD
Sorafenib—Gastrointestinal pain—Methylprednisolone—gout	7.02e-05	0.000537	CcSEcCtD
Sorafenib—CYP2B6—Cytochrome P450 - arranged by substrate type—POMC—gout	6.92e-05	0.00226	CbGpPWpGaD
Sorafenib—Hypersensitivity—Prednisolone—gout	6.89e-05	0.000527	CcSEcCtD
Sorafenib—Urticaria—Methylprednisolone—gout	6.82e-05	0.000522	CcSEcCtD
Sorafenib—Anaphylactic shock—Prednisone—gout	6.79e-05	0.00052	CcSEcCtD
Sorafenib—Abdominal pain—Methylprednisolone—gout	6.78e-05	0.000519	CcSEcCtD
Sorafenib—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—gout	6.77e-05	0.00221	CbGpPWpGaD
Sorafenib—Infection—Prednisone—gout	6.75e-05	0.000517	CcSEcCtD
Sorafenib—PDGFRB—Disease—PRPS1—gout	6.74e-05	0.0022	CbGpPWpGaD
Sorafenib—PDGFRB—Disease—PRPS2—gout	6.74e-05	0.0022	CbGpPWpGaD
Sorafenib—Hypersensitivity—Hydrocortisone—gout	6.73e-05	0.000515	CcSEcCtD
Sorafenib—Shock—Prednisone—gout	6.68e-05	0.000512	CcSEcCtD
Sorafenib—Nervous system disorder—Prednisone—gout	6.66e-05	0.00051	CcSEcCtD
Sorafenib—ABCG2—Transmembrane transport of small molecules—SLC2A9—gout	6.6e-05	0.00216	CbGpPWpGaD
Sorafenib—Skin disorder—Prednisone—gout	6.6e-05	0.000505	CcSEcCtD
Sorafenib—Asthenia—Hydrocortisone—gout	6.55e-05	0.000502	CcSEcCtD
Sorafenib—Anorexia—Prednisone—gout	6.48e-05	0.000496	CcSEcCtD
Sorafenib—EPHX2—Metabolism—ABCG2—gout	6.47e-05	0.00212	CbGpPWpGaD
Sorafenib—Pruritus—Hydrocortisone—gout	6.46e-05	0.000495	CcSEcCtD
Sorafenib—RAF1—Cytokine Signaling in Immune system—CASP1—gout	6.44e-05	0.00211	CbGpPWpGaD
Sorafenib—UGT1A1—Metabolism—BCKDHA—gout	6.34e-05	0.00207	CbGpPWpGaD
Sorafenib—UGT1A9—Metabolism—BCKDHA—gout	6.34e-05	0.00207	CbGpPWpGaD
Sorafenib—Hypersensitivity—Methylprednisolone—gout	6.32e-05	0.000484	CcSEcCtD
Sorafenib—MAPK11—Immune System—NLRP3—gout	6.29e-05	0.00206	CbGpPWpGaD
Sorafenib—Diarrhoea—Hydrocortisone—gout	6.25e-05	0.000478	CcSEcCtD
Sorafenib—RAF1—Cytokine Signaling in Immune system—IL1RN—gout	6.24e-05	0.00204	CbGpPWpGaD
Sorafenib—EPHX2—Metabolism of lipids and lipoproteins—POMC—gout	6.22e-05	0.00203	CbGpPWpGaD
Sorafenib—ABCB1—Transmembrane transport of small molecules—SLC17A3—gout	6.21e-05	0.00203	CbGpPWpGaD
Sorafenib—Musculoskeletal discomfort—Prednisone—gout	6.19e-05	0.000474	CcSEcCtD
Sorafenib—Dizziness—Prednisolone—gout	6.18e-05	0.000473	CcSEcCtD
Sorafenib—Asthenia—Methylprednisolone—gout	6.16e-05	0.000471	CcSEcCtD
Sorafenib—Pruritus—Methylprednisolone—gout	6.07e-05	0.000465	CcSEcCtD
Sorafenib—Dizziness—Hydrocortisone—gout	6.04e-05	0.000462	CcSEcCtD
Sorafenib—RAF1—Disease—PRPS1—gout	6.01e-05	0.00196	CbGpPWpGaD
Sorafenib—RAF1—Disease—PRPS2—gout	6.01e-05	0.00196	CbGpPWpGaD
Sorafenib—Dyspepsia—Prednisone—gout	5.98e-05	0.000458	CcSEcCtD
Sorafenib—Decreased appetite—Prednisone—gout	5.91e-05	0.000452	CcSEcCtD
Sorafenib—Rash—Prednisolone—gout	5.9e-05	0.000451	CcSEcCtD
Sorafenib—Dermatitis—Prednisolone—gout	5.89e-05	0.000451	CcSEcCtD
Sorafenib—Diarrhoea—Methylprednisolone—gout	5.87e-05	0.000449	CcSEcCtD
Sorafenib—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—gout	5.86e-05	0.00192	CbGpPWpGaD
Sorafenib—Fatigue—Prednisone—gout	5.86e-05	0.000448	CcSEcCtD
Sorafenib—Headache—Prednisolone—gout	5.86e-05	0.000448	CcSEcCtD
Sorafenib—Constipation—Prednisone—gout	5.81e-05	0.000445	CcSEcCtD
Sorafenib—Vomiting—Hydrocortisone—gout	5.81e-05	0.000444	CcSEcCtD
Sorafenib—Rash—Hydrocortisone—gout	5.76e-05	0.000441	CcSEcCtD
Sorafenib—Dermatitis—Hydrocortisone—gout	5.75e-05	0.00044	CcSEcCtD
Sorafenib—Headache—Hydrocortisone—gout	5.72e-05	0.000438	CcSEcCtD
Sorafenib—Dizziness—Methylprednisolone—gout	5.67e-05	0.000434	CcSEcCtD
Sorafenib—MAP3K7—Immune System—NLRP3—gout	5.67e-05	0.00185	CbGpPWpGaD
Sorafenib—KIT—Immune System—NLRP3—gout	5.67e-05	0.00185	CbGpPWpGaD
Sorafenib—CYP2B6—Phase 1 - Functionalization of compounds—POMC—gout	5.61e-05	0.00184	CbGpPWpGaD
Sorafenib—Gastrointestinal pain—Prednisone—gout	5.56e-05	0.000425	CcSEcCtD
Sorafenib—Nausea—Prednisolone—gout	5.55e-05	0.000425	CcSEcCtD
Sorafenib—CYP3A5—Phase 1 - Functionalization of compounds—POMC—gout	5.48e-05	0.00179	CbGpPWpGaD
Sorafenib—Vomiting—Methylprednisolone—gout	5.45e-05	0.000418	CcSEcCtD
Sorafenib—Nausea—Hydrocortisone—gout	5.42e-05	0.000415	CcSEcCtD
Sorafenib—Rash—Methylprednisolone—gout	5.41e-05	0.000414	CcSEcCtD
Sorafenib—Dermatitis—Methylprednisolone—gout	5.4e-05	0.000414	CcSEcCtD
Sorafenib—Urticaria—Prednisone—gout	5.4e-05	0.000413	CcSEcCtD
Sorafenib—ABCG2—Metabolism—BCKDHA—gout	5.38e-05	0.00176	CbGpPWpGaD
Sorafenib—FGFR1—Immune System—NLRP3—gout	5.38e-05	0.00176	CbGpPWpGaD
Sorafenib—Headache—Methylprednisolone—gout	5.37e-05	0.000411	CcSEcCtD
Sorafenib—Abdominal pain—Prednisone—gout	5.37e-05	0.000411	CcSEcCtD
Sorafenib—Body temperature increased—Prednisone—gout	5.37e-05	0.000411	CcSEcCtD
Sorafenib—PDGFRA—Immune System—NLRP3—gout	5.37e-05	0.00176	CbGpPWpGaD
Sorafenib—CYP3A7—Metabolism—BCKDHA—gout	5.34e-05	0.00174	CbGpPWpGaD
Sorafenib—MAPK11—Innate Immune System—CASP1—gout	5.27e-05	0.00172	CbGpPWpGaD
Sorafenib—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—gout	5.23e-05	0.00171	CbGpPWpGaD
Sorafenib—UGT1A1—Metabolism—PRPS1—gout	5.17e-05	0.00169	CbGpPWpGaD
Sorafenib—UGT1A1—Metabolism—HPRT1—gout	5.17e-05	0.00169	CbGpPWpGaD
Sorafenib—UGT1A1—Metabolism—PRPS2—gout	5.17e-05	0.00169	CbGpPWpGaD
Sorafenib—UGT1A9—Metabolism—PRPS2—gout	5.17e-05	0.00169	CbGpPWpGaD
Sorafenib—UGT1A9—Metabolism—PRPS1—gout	5.17e-05	0.00169	CbGpPWpGaD
Sorafenib—UGT1A9—Metabolism—HPRT1—gout	5.17e-05	0.00169	CbGpPWpGaD
Sorafenib—Nausea—Methylprednisolone—gout	5.1e-05	0.00039	CcSEcCtD
Sorafenib—ABCB1—Transmembrane transport of small molecules—SLC22A11—gout	5.06e-05	0.00166	CbGpPWpGaD
Sorafenib—ABCB1—Transmembrane transport of small molecules—SLC17A1—gout	5.06e-05	0.00166	CbGpPWpGaD
Sorafenib—Hypersensitivity—Prednisone—gout	5.01e-05	0.000383	CcSEcCtD
Sorafenib—Asthenia—Prednisone—gout	4.87e-05	0.000373	CcSEcCtD
Sorafenib—PDGFRB—Immune System—NLRP3—gout	4.84e-05	0.00158	CbGpPWpGaD
Sorafenib—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—gout	4.81e-05	0.00157	CbGpPWpGaD
Sorafenib—Pruritus—Prednisone—gout	4.81e-05	0.000368	CcSEcCtD
Sorafenib—UGT1A1—Biological oxidations—POMC—gout	4.79e-05	0.00157	CbGpPWpGaD
Sorafenib—UGT1A9—Biological oxidations—POMC—gout	4.79e-05	0.00157	CbGpPWpGaD
Sorafenib—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—gout	4.77e-05	0.00156	CbGpPWpGaD
Sorafenib—KIT—Innate Immune System—CASP1—gout	4.75e-05	0.00155	CbGpPWpGaD
Sorafenib—MAP3K7—Innate Immune System—CASP1—gout	4.75e-05	0.00155	CbGpPWpGaD
Sorafenib—CYP2C8—Phase 1 - Functionalization of compounds—POMC—gout	4.75e-05	0.00155	CbGpPWpGaD
Sorafenib—ABCC4—Transmembrane transport of small molecules—ABCG2—gout	4.73e-05	0.00155	CbGpPWpGaD
Sorafenib—Diarrhoea—Prednisone—gout	4.65e-05	0.000356	CcSEcCtD
Sorafenib—FGFR1—Innate Immune System—CASP1—gout	4.51e-05	0.00148	CbGpPWpGaD
Sorafenib—PDGFRA—Innate Immune System—CASP1—gout	4.5e-05	0.00147	CbGpPWpGaD
Sorafenib—Dizziness—Prednisone—gout	4.49e-05	0.000344	CcSEcCtD
Sorafenib—ABCG2—Metabolism—PRPS1—gout	4.39e-05	0.00143	CbGpPWpGaD
Sorafenib—ABCG2—Metabolism—PRPS2—gout	4.39e-05	0.00143	CbGpPWpGaD
Sorafenib—ABCG2—Metabolism—HPRT1—gout	4.39e-05	0.00143	CbGpPWpGaD
Sorafenib—CYP3A7—Metabolism—PRPS2—gout	4.35e-05	0.00142	CbGpPWpGaD
Sorafenib—CYP3A7—Metabolism—PRPS1—gout	4.35e-05	0.00142	CbGpPWpGaD
Sorafenib—CYP3A7—Metabolism—HPRT1—gout	4.35e-05	0.00142	CbGpPWpGaD
Sorafenib—Vomiting—Prednisone—gout	4.32e-05	0.000331	CcSEcCtD
Sorafenib—RAF1—Immune System—NLRP3—gout	4.31e-05	0.00141	CbGpPWpGaD
Sorafenib—Rash—Prednisone—gout	4.28e-05	0.000328	CcSEcCtD
Sorafenib—Dermatitis—Prednisone—gout	4.28e-05	0.000328	CcSEcCtD
Sorafenib—Headache—Prednisone—gout	4.26e-05	0.000326	CcSEcCtD
Sorafenib—CYP2C19—Phase 1 - Functionalization of compounds—POMC—gout	4.24e-05	0.00139	CbGpPWpGaD
Sorafenib—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—gout	4.08e-05	0.00133	CbGpPWpGaD
Sorafenib—PDGFRB—Innate Immune System—CASP1—gout	4.05e-05	0.00133	CbGpPWpGaD
Sorafenib—Nausea—Prednisone—gout	4.04e-05	0.000309	CcSEcCtD
Sorafenib—CYP3A7—Biological oxidations—POMC—gout	4.03e-05	0.00132	CbGpPWpGaD
Sorafenib—ABCC2—Transmembrane transport of small molecules—ABCG2—gout	3.99e-05	0.0013	CbGpPWpGaD
Sorafenib—RAF1—Transmembrane transport of small molecules—ABCG2—gout	3.98e-05	0.0013	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—BCKDHA—gout	3.95e-05	0.00129	CbGpPWpGaD
Sorafenib—CYP2D6—Phase 1 - Functionalization of compounds—POMC—gout	3.9e-05	0.00128	CbGpPWpGaD
Sorafenib—CYP2C9—Phase 1 - Functionalization of compounds—POMC—gout	3.87e-05	0.00126	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—BCKDHA—gout	3.86e-05	0.00126	CbGpPWpGaD
Sorafenib—ABCB1—Transmembrane transport of small molecules—SLC22A12—gout	3.84e-05	0.00126	CbGpPWpGaD
Sorafenib—RAF1—Innate Immune System—CASP1—gout	3.61e-05	0.00118	CbGpPWpGaD
Sorafenib—ABCB1—Transmembrane transport of small molecules—SLC2A9—gout	3.57e-05	0.00117	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—BCKDHA—gout	3.34e-05	0.00109	CbGpPWpGaD
Sorafenib—CYP1A2—Phase 1 - Functionalization of compounds—POMC—gout	3.3e-05	0.00108	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—PRPS2—gout	3.22e-05	0.00105	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—HPRT1—gout	3.22e-05	0.00105	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—PRPS1—gout	3.22e-05	0.00105	CbGpPWpGaD
Sorafenib—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—gout	3.15e-05	0.00103	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—PRPS1—gout	3.14e-05	0.00103	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—HPRT1—gout	3.14e-05	0.00103	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—PRPS2—gout	3.14e-05	0.00103	CbGpPWpGaD
Sorafenib—HTR2B—Class A/1 (Rhodopsin-like receptors)—POMC—gout	3.09e-05	0.00101	CbGpPWpGaD
Sorafenib—MAPK11—Immune System—CASP1—gout	3.07e-05	0.001	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—BCKDHA—gout	2.98e-05	0.000975	CbGpPWpGaD
Sorafenib—CYP2B6—Biological oxidations—POMC—gout	2.98e-05	0.000975	CbGpPWpGaD
Sorafenib—MAPK11—Immune System—IL1RN—gout	2.97e-05	0.000973	CbGpPWpGaD
Sorafenib—CYP3A5—Biological oxidations—POMC—gout	2.91e-05	0.000953	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—BCKDHA—gout	2.91e-05	0.000952	CbGpPWpGaD
Sorafenib—EPHX2—Metabolism—POMC—gout	2.77e-05	0.000906	CbGpPWpGaD
Sorafenib—KIT—Immune System—CASP1—gout	2.77e-05	0.000906	CbGpPWpGaD
Sorafenib—MAP3K7—Immune System—CASP1—gout	2.77e-05	0.000906	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—BCKDHA—gout	2.74e-05	0.000897	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—PRPS1—gout	2.72e-05	0.00089	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—HPRT1—gout	2.72e-05	0.00089	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—PRPS2—gout	2.72e-05	0.00089	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—BCKDHA—gout	2.72e-05	0.000889	CbGpPWpGaD
Sorafenib—KIT—Immune System—IL1RN—gout	2.68e-05	0.000877	CbGpPWpGaD
Sorafenib—MAP3K7—Immune System—IL1RN—gout	2.68e-05	0.000877	CbGpPWpGaD
Sorafenib—FGFR1—Immune System—CASP1—gout	2.63e-05	0.000859	CbGpPWpGaD
Sorafenib—PDGFRA—Immune System—CASP1—gout	2.62e-05	0.000857	CbGpPWpGaD
Sorafenib—CYP3A4—Phase 1 - Functionalization of compounds—POMC—gout	2.55e-05	0.000834	CbGpPWpGaD
Sorafenib—FGFR1—Immune System—IL1RN—gout	2.55e-05	0.000832	CbGpPWpGaD
Sorafenib—PDGFRA—Immune System—IL1RN—gout	2.54e-05	0.00083	CbGpPWpGaD
Sorafenib—CYP2C8—Biological oxidations—POMC—gout	2.52e-05	0.000825	CbGpPWpGaD
Sorafenib—HTR2C—Class A/1 (Rhodopsin-like receptors)—POMC—gout	2.49e-05	0.000815	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—PRPS1—gout	2.43e-05	0.000795	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—PRPS2—gout	2.43e-05	0.000795	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—HPRT1—gout	2.43e-05	0.000795	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—PRPS2—gout	2.37e-05	0.000776	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—HPRT1—gout	2.37e-05	0.000776	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—PRPS1—gout	2.37e-05	0.000776	CbGpPWpGaD
Sorafenib—PDGFRB—Immune System—CASP1—gout	2.36e-05	0.000772	CbGpPWpGaD
Sorafenib—HTR2B—GPCR ligand binding—POMC—gout	2.35e-05	0.000769	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—BCKDHA—gout	2.32e-05	0.00076	CbGpPWpGaD
Sorafenib—RALBP1—Signaling Pathways—POMC—gout	2.32e-05	0.000757	CbGpPWpGaD
Sorafenib—PDGFRB—Immune System—IL1RN—gout	2.29e-05	0.000748	CbGpPWpGaD
Sorafenib—FLT4—Signaling Pathways—POMC—gout	2.28e-05	0.000745	CbGpPWpGaD
Sorafenib—CYP2C19—Biological oxidations—POMC—gout	2.25e-05	0.000737	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—PRPS1—gout	2.24e-05	0.000731	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—HPRT1—gout	2.24e-05	0.000731	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—PRPS2—gout	2.24e-05	0.000731	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—HPRT1—gout	2.22e-05	0.000725	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—PRPS1—gout	2.22e-05	0.000725	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—PRPS2—gout	2.22e-05	0.000725	CbGpPWpGaD
Sorafenib—RAF1—Immune System—CASP1—gout	2.1e-05	0.000688	CbGpPWpGaD
Sorafenib—CYP2D6—Biological oxidations—POMC—gout	2.07e-05	0.000678	CbGpPWpGaD
Sorafenib—CYP2C9—Biological oxidations—POMC—gout	2.05e-05	0.000672	CbGpPWpGaD
Sorafenib—RAF1—Immune System—IL1RN—gout	2.04e-05	0.000667	CbGpPWpGaD
Sorafenib—UGT1A1—Metabolism—ABCG2—gout	1.91e-05	0.000626	CbGpPWpGaD
Sorafenib—UGT1A9—Metabolism—ABCG2—gout	1.91e-05	0.000626	CbGpPWpGaD
Sorafenib—HTR2C—GPCR ligand binding—POMC—gout	1.9e-05	0.000621	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—PRPS2—gout	1.89e-05	0.000619	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—HPRT1—gout	1.89e-05	0.000619	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—PRPS1—gout	1.89e-05	0.000619	CbGpPWpGaD
Sorafenib—MKNK1—Signaling Pathways—POMC—gout	1.89e-05	0.000617	CbGpPWpGaD
Sorafenib—ABCB1—Transmembrane transport of small molecules—ABCG2—gout	1.87e-05	0.000613	CbGpPWpGaD
Sorafenib—UGT1A9—Metabolism of lipids and lipoproteins—POMC—gout	1.84e-05	0.000602	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—BCKDHA—gout	1.79e-05	0.000586	CbGpPWpGaD
Sorafenib—CYP1A2—Biological oxidations—POMC—gout	1.76e-05	0.000574	CbGpPWpGaD
Sorafenib—FLT1—Signaling Pathways—POMC—gout	1.7e-05	0.000556	CbGpPWpGaD
Sorafenib—CYP3A7—Metabolism—ABCG2—gout	1.61e-05	0.000526	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—HPRT1—gout	1.46e-05	0.000478	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—PRPS2—gout	1.46e-05	0.000478	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—PRPS1—gout	1.46e-05	0.000478	CbGpPWpGaD
Sorafenib—CYP3A4—Biological oxidations—POMC—gout	1.35e-05	0.000443	CbGpPWpGaD
Sorafenib—HTR2B—GPCR downstream signaling—POMC—gout	1.33e-05	0.000435	CbGpPWpGaD
Sorafenib—HTR2B—Signaling by GPCR—POMC—gout	1.21e-05	0.000395	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—ABCG2—gout	1.19e-05	0.000389	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—ABCG2—gout	1.16e-05	0.000381	CbGpPWpGaD
Sorafenib—MAP2K5—Signaling Pathways—POMC—gout	1.16e-05	0.00038	CbGpPWpGaD
Sorafenib—KDR—Signaling Pathways—POMC—gout	1.13e-05	0.00037	CbGpPWpGaD
Sorafenib—RAF1—Signaling by GPCR—POMC—gout	1.13e-05	0.000369	CbGpPWpGaD
Sorafenib—HTR2C—GPCR downstream signaling—POMC—gout	1.07e-05	0.000351	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—ABCG2—gout	1.01e-05	0.00033	CbGpPWpGaD
Sorafenib—HTR2C—Signaling by GPCR—POMC—gout	9.74e-06	0.000319	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—POMC—gout	9.73e-06	0.000318	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism of lipids and lipoproteins—POMC—gout	9.69e-06	0.000317	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—POMC—gout	9.64e-06	0.000315	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—ABCG2—gout	9e-06	0.000294	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—ABCG2—gout	8.78e-06	0.000287	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—POMC—gout	8.77e-06	0.000287	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—POMC—gout	8.77e-06	0.000287	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism of lipids and lipoproteins—POMC—gout	8.65e-06	0.000283	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—POMC—gout	8.32e-06	0.000272	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—POMC—gout	8.3e-06	0.000272	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—ABCG2—gout	8.27e-06	0.000271	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—ABCG2—gout	8.2e-06	0.000268	CbGpPWpGaD
Sorafenib—UGT1A1—Metabolism—POMC—gout	8.2e-06	0.000268	CbGpPWpGaD
Sorafenib—UGT1A9—Metabolism—POMC—gout	8.2e-06	0.000268	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism of lipids and lipoproteins—POMC—gout	7.89e-06	0.000258	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—POMC—gout	7.48e-06	0.000245	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—POMC—gout	7.13e-06	0.000233	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—ABCG2—gout	7.01e-06	0.000229	CbGpPWpGaD
Sorafenib—ABCG2—Metabolism—POMC—gout	6.95e-06	0.000227	CbGpPWpGaD
Sorafenib—CYP3A7—Metabolism—POMC—gout	6.89e-06	0.000225	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism of lipids and lipoproteins—POMC—gout	6.74e-06	0.00022	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—POMC—gout	6.67e-06	0.000218	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—POMC—gout	5.75e-06	0.000188	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—ABCG2—gout	5.41e-06	0.000177	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—POMC—gout	5.1e-06	0.000167	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—POMC—gout	4.98e-06	0.000163	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—POMC—gout	4.32e-06	0.000141	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—POMC—gout	3.85e-06	0.000126	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—POMC—gout	3.76e-06	0.000123	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—POMC—gout	3.54e-06	0.000116	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—POMC—gout	3.51e-06	0.000115	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—POMC—gout	3e-06	9.82e-05	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—POMC—gout	2.32e-06	7.58e-05	CbGpPWpGaD
